Dry eye syndrome, also known as keratoconjunctivitis sicca, is the condition of having dry eyes where either the eyes are not capable of producing sufficient tears to maintain lubrication or the when produced, they evaporate too quickly. The condition can lead to various difficulties in the daily life of a person, such as reading for an extended period of time or using a computer. The condition can decrease the tolerance of a person in a dry environment such as air present inside an airplane.
Dry eye syndrome is gaining prominence due to the changing lifestyles, consumption of specified medicines, and increased rate of diseases. Autoimmune diseases, genetic factors, environmental conditions, and routine practices such as extended usage of contact lenses and prolonged computer usage also cause dry eye syndrome.
The dry eye syndrome drugs market is moderately populated owing to the presence of few key vendors competing intensely with smaller vendors. Vendors in the dry eye medication market compete based on the long-term efficacy of the drugs with minimum side effects. Dry eye syndrome drug manufacturers cater extensively to hospitals and pharmacies.

The global Dry Eye Syndrome market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Dry Eye Syndrome volume and value at global level, regional level and company level. From a global perspective, this report represents overall Dry Eye Syndrome market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Dry Eye Syndrome in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Dry Eye Syndrome manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Allergan
Novartis
Otsuka Holdings
Santen Pharmaceutical
Aerie Pharmaceutical
Akorn
Bausch & Lomb
Johnson & Johnson
Merck
MIMETOGEN
ReGenTree
Sun Pharmaceutical
Teva Pharmaceutical

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Prescription drugs
Over-the-counter (OTC) drugs

Segment by Application
Hospitals and Clinics
Medical Laboratories
Others